HA
CVS icon

Herold Advisors’s CVS Health CVS Stock Holding History

Herold Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$864K Sell
8,322
-1,154
-12% -$103K 0.17% 132
2026
Q1 		$681K Sell
9,476
-642
-6% -$49.5K 0.15% 144
2025
Q4 		$803K Buy
10,118
+9
+0.1% +$710 0.18% 124
2025
Q3 		$762K Sell
10,109
-867
-8% -$59.4K 0.18% 133
2025
Q2 		$757K Sell
10,976
-714
-6% -$46.8K 0.16% 143
2025
Q1 		$792K Sell
11,690
-687
-6% -$41.1K 0.17% 137
2024
Q4 		$556K Sell
12,377
-5,080
-29% -$285K 0.12% 175
2024
Q3 		$1.1M Sell
17,457
-6,269
-26% -$366K 0.24% 117
2024
Q2 		$1.4M Buy
23,726
+2
+0% +$125 0.32% 84
2024
Q1 		$1.89M Sell
23,724
-241
-1% -$18.4K 0.46% 63
2023
Q4 		$1.89M Buy
23,965
+333
+1% +$23.7K 0.52% 60
2023
Q3 		$1.65M Sell
23,632
-6,010
-20% -$426K 0.5% 59
2023
Q2 		$2.05M Buy
29,642
+3,104
+12% +$221K 0.63% 44
2023
Q1 		$1.97M Buy
26,538
+2,835
+12% +$238K 0.68% 41
2022
Q4 		$2.21M Sell
23,703
-6,738
-22% -$650K 0.94% 27
2022
Q3 		$2.9M Sell
30,441
-170
-0.6% -$16.8K 1.4% 12
2022
Q2 		$2.84M Buy
30,611
+606
+2% +$59.1K 1.26% 16
2022
Q1 		$3.04M Buy
30,005
+18,366
+158% +$1.93M 1.08% 15
2021
Q4 		$1.2M Sell
11,639
-392
-3% -$36.2K 0.47% 75
2021
Q3 		$1.02M Buy
+12,031
New +$1.01M 0.4% 79

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Herold Advisors's CVS Position: Q2 2026 in Review

Herold Advisors reduced its CVS Health (CVS) stake by 12% in Q2 2026, selling an estimated $103K and leaving 8,322 shares worth $864K. The position accounts for 0.17% of the portfolio, ranked #132.

Herold Advisors first reported a position in CVS in Q3 2021 and has held it in 20 quarters since. The position peaked at $3.04M in Q1 2022. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Herold Advisors held 8,322 shares of CVS Health worth $864K as of Q2 2026.
  • Herold Advisors sold 1,154 CVS Health shares in Q2 2026, an estimated $103K.
  • CVS Health made up 0.17% of Herold Advisors's portfolio in Q2 2026, its #132 holding.
  • Herold Advisors first reported a position in CVS Health in Q3 2021 and has held it in 20 quarters since.
  • Herold Advisors's CVS Health position peaked at $3.04M in Q1 2022.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Herold Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.